14-day Premium Trial Subscription Try For FreeTry Free
$12.48
-0.440 (-3.41%)
At Close: Apr 25, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $12.40 $17.80 Thursday, 25th Apr 2024 ENTA stock ended at $12.48. This is 3.41% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 2.72% from a day low at $12.40 to a day high of $12.74.
90 days $11.01 $17.80
52 weeks $8.08 $37.75

Historical Enanta Pharmaceuticals prices

Date Open High Low Close Volume
Dec 07, 2020 $42.45 $42.87 $41.70 $42.62 140 972
Dec 04, 2020 $41.35 $43.13 $41.35 $42.67 153 935
Dec 03, 2020 $42.29 $42.60 $41.53 $41.86 112 157
Dec 02, 2020 $41.30 $42.34 $40.85 $42.07 154 365
Dec 01, 2020 $41.24 $42.23 $40.62 $41.16 240 897
Nov 30, 2020 $42.72 $43.00 $41.01 $41.20 243 308
Nov 27, 2020 $42.79 $43.21 $41.93 $42.90 82 980
Nov 25, 2020 $43.01 $44.67 $42.93 $42.94 151 198
Nov 24, 2020 $41.57 $45.00 $40.46 $42.89 328 025
Nov 23, 2020 $44.26 $45.14 $43.24 $43.67 112 242
Nov 20, 2020 $43.76 $44.38 $43.14 $43.57 148 530
Nov 19, 2020 $44.40 $44.97 $43.82 $44.15 94 858
Nov 18, 2020 $45.64 $46.32 $44.15 $44.19 174 948
Nov 17, 2020 $45.29 $45.86 $44.31 $45.65 101 474
Nov 16, 2020 $45.81 $46.55 $44.32 $45.34 157 209
Nov 13, 2020 $46.27 $47.11 $44.87 $45.12 124 566
Nov 12, 2020 $47.19 $47.23 $45.75 $45.92 94 289
Nov 11, 2020 $47.57 $47.71 $46.40 $47.47 63 668
Nov 10, 2020 $45.50 $47.87 $44.90 $47.08 173 753
Nov 09, 2020 $46.05 $46.95 $45.02 $45.18 134 226
Nov 06, 2020 $45.23 $45.39 $43.61 $44.28 108 275
Nov 05, 2020 $46.64 $47.35 $45.24 $45.34 248 543
Nov 04, 2020 $45.20 $47.56 $45.20 $46.08 245 291
Nov 03, 2020 $44.54 $45.69 $44.26 $44.88 107 393
Nov 02, 2020 $44.05 $44.58 $43.17 $44.31 119 832
Click to get the best stock tips daily for free!

About Enanta Pharmaceuticals

Enanta Pharmaceuticals Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A pro... ENTA Profile

Golden Star

Ticker Date Change Price
MLI Apr 19 11.73% $52.28
LPLA Apr 19 1.08% $262.59
DOOR Apr 18 0.274% $131.39
LNG Apr 17 1.63% $156.81
FCN Apr 16 3.70% $207.62
ELV Apr 16 6.45% $506.97
AKR Apr 05 5.14% $16.53
ITCI Apr 05 5.39% $68.44
SARK Mar 28 14.47% $26.88
ARCC Mar 25 2.53% $20.12
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT